ipamorelin sleep quality study CJC-1295 + Ipamorelin UK: Research Status, Testing

Disclosures: Daniel Yan Zheng Lim: Nothing to Disclose, Siyuan Yin: Nothing to Disclose, Charlene Tan Hui Ru: Nothing to Disclose, Jeanette Ng: Nothing to Disclose, Chee-Kiat Tan: Eisai: Advisor, Abbott Laboratories: Advisor, Gilead Sciences: Advisor, Roche Diagnostics: Advisor, Fujifilm: Advisor, George Boon Bee Goh: Nothing to Disclose 2066 MULTIPLEXED IN VIVO SCREENING REVEALS THE DELETERIOUS EFFECTS OF FIBROGENIC FACTORS ON HEPATOCYTES Joanne Hsieh 1 Vinay Kartha 1 Hikaru Miyazaki 1 Christopher Carrico 1 Linda Chio 1 Daniel Fuentes 1 Dimitry Popov 1 Ian Driver 1 Chris Towne 1 Francisco LePort 1 Martin Borch Jensen 1 , 1 Gordian Biotechnology Background: Hepatocyte injury and death promotes fibrosis deposition, but the ramifications of extracellular matrix composition on hepatocytes is less understood

Baldo P, Doree C, Molin P, McFerran D, Cecco S

Katas H, Moden NZ, Lim CS, Celesistinus T, Chan JY, Ganasan P et al (2018) Biosynthesis and potential applications of silver and gold nanoparticles and their chitosan-based nanocomposites in nanomedicine

The main challenge faced by the research team was maintaining high plasma stability in vivo while ensuring efficient payload release triggered by -Galactosidase within target cells